172 related articles for article (PubMed ID: 33710368)
1. Combining UBR5 and CD163
Wang C; Hong T; Wang Y; Peng G; Yu Y; Zhang J; Zhuo D; Zheng J; Ma X; Cui X
Cancer Immunol Immunother; 2021 Oct; 70(10):2925-2935. PubMed ID: 33710368
[TBL] [Abstract][Full Text] [Related]
2. Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patients.
Wang C; Hong T; Wang Y; Gan S; Wang Q; Li J; Zuo L; Cui X
Oncoimmunology; 2020; 9(1):1736793. PubMed ID: 32313718
[TBL] [Abstract][Full Text] [Related]
3. Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma.
Wang C; Dong K; Wang Y; Peng G; Song X; Yu Y; Shen P; Cui X
BMC Cancer; 2021 Aug; 21(1):890. PubMed ID: 34348693
[TBL] [Abstract][Full Text] [Related]
4. Combining expression of RNF43 and infiltration level of CD163
Zhu D; Shi X; Tian Y; Li H; Tang B; Zhang Z; Zhang Z; Zuo L
Cancer Med; 2023 Feb; 12(4):3962-3971. PubMed ID: 36097369
[TBL] [Abstract][Full Text] [Related]
5. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
6. CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma.
Ma C; Horlad H; Ohnishi K; Nakagawa T; Yamada S; Kitada S; Motoshima T; Kamba T; Nakayama T; Fujimoto N; Takeya M; Komohara Y
Med Mol Morphol; 2018 Mar; 51(1):13-20. PubMed ID: 28687956
[TBL] [Abstract][Full Text] [Related]
7. Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Ye J; Chu C; Zuo L; Zhang J; Cui X
Cell Death Differ; 2021 Mar; 28(3):932-951. PubMed ID: 33009518
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
9. RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma.
Zhu D; Zhang L; Shi X; Gao S; Yue C; Zhang L; Bai YU; Wang Q; Okada A; Yasui T; Wang C; Cui X; Zuo LI
Oncol Res; 2021; 29(3):159-174. PubMed ID: 37304674
[TBL] [Abstract][Full Text] [Related]
10. Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer.
Park JY; Sung JY; Lee J; Park YK; Kim YW; Kim GY; Won KY; Lim SJ
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):357-365. PubMed ID: 26508473
[TBL] [Abstract][Full Text] [Related]
11. The Ratio of CD86+/CD163+ Macrophages Predicts Postoperative Recurrence in Stage II-III Colorectal Cancer.
Xu G; Jiang L; Ye C; Qin G; Luo Z; Mo Y; Chen J
Front Immunol; 2021; 12():724429. PubMed ID: 34512652
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CD68
Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of diametrically polarized tumor-associated macrophages in renal cell carcinoma.
Xu L; Zhu Y; Chen L; An H; Zhang W; Wang G; Lin Z; Xu J
Ann Surg Oncol; 2014 Sep; 21(9):3142-50. PubMed ID: 24615178
[TBL] [Abstract][Full Text] [Related]
14. CD163
Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S
Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107
[TBL] [Abstract][Full Text] [Related]
15. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
[TBL] [Abstract][Full Text] [Related]
16. Elevated CD163
Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
[No Abstract] [Full Text] [Related]
17. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of Siglec-8 expression predicts adverse prognosis in patients with clear cell renal cell carcinoma.
Ou C; Liu L; Wang J; Dai S; Qu Y; Xiong Y; Xi W; Xu J; Guo J
Urol Oncol; 2017 Oct; 35(10):607.e1-607.e8. PubMed ID: 28619634
[TBL] [Abstract][Full Text] [Related]
19. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
Laba P; Wang J; Zhang J
BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of pSTAT1 and CD163 Expressions in Surgically Resected Stage 1 Pulmonary Squamous Cell Carcinomas.
Lin MW; Yang CY; Kuo SW; Wu CT; Chang YL; Yang PC
Ann Surg Oncol; 2016 Sep; 23(9):3071-81. PubMed ID: 27150441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]